Old Web
2019 biotech IPOs: party on
2020
Continued VC largesse and a maturing biotech industry in China helped boost 2019’s IPO totals. Continued VC largesse and a maturing biotech industry in China helped boost 2019’s IPO totals.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI